Form 8-K - Current report:
SEC Accession No. 0000950123-09-013065
Filing Date
2009-06-11
Accepted
2009-06-10 18:08:13
Documents
5
Period of Report
2009-06-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a52847e8vk.htm 8-K 21414
2 EX-99.1 a52847exv99w1.htm EX-99.1 194817
3 EX-99.2 a52847exv99w2.htm EX-99.2 504800
4 EX-99.3 a52847exv99w3.htm EX-99.3 143062
5 EX-99.4 a52847exv99w4.htm EX-99.4 72926
  Complete submission text file 0000950123-09-013065.txt   938895
Mailing Address ONE ENTERPRISE ALISO VIEJO CA 92656
Business Address ONE ENTERPRISE ALISO VIEJO CA 92656 949-461-6000
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11397 | Film No.: 09885599
SIC: 2834 Pharmaceutical Preparations